| Literature DB >> 29891597 |
Yubhisha Dabas1, Immaculata Xess2, Sameer Bakshi3, Manoranjan Mahapatra4, Rachna Seth5.
Abstract
This prospective study shows that the rate of azole-resistant Aspergillus fumigatus (ARAF) in an immunocompromised Indian patient population with invasive aspergillosis (IA) is low, 6/706 (0.8%). This low rate supports the continued use of voriconazole as the first line of treatment. However, the ARAF isolates from India in this study exhibited three kinds of unreported cyp51A mutations, of which two were at hot spots, G54R and P216L, while one was at codon Y431C.Entities:
Keywords: India; antifungal susceptibility testing; azole-resistant Aspergillus fumigatus; cyp51A mutations; immunocompromised hosts; invasive aspergillosis; risk factor
Mesh:
Substances:
Year: 2018 PMID: 29891597 PMCID: PMC6105863 DOI: 10.1128/AAC.02264-17
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191